Electrofisiología Cardíaca Celular

Sanchez, M; Romero, M; Gomez-Guzman, M; Tamargo, J; Perez-Vizcaino, F; Duarte, J.

Cardiovascular Effects of Flavonoids

CURRENT MEDICINAL CHEMISTRY. 2019; 26(39): 6991-7034 Nº de citas: 54 [doi:10.2174/0929867326666181220094721]

Tamargo, J.

Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments

EUROPEAN CARDIOLOGY REVIEW. 2019; 14(1): 23-32 Nº de citas: 47 [doi:10.15420/ecr.2018.34.2]

Vonbank, A; Drexel, H; Agewall, S; Lewis, BS; Dopheide, JF; Kjeldsen, K; Ceconi, C; Savarese, G; Rosano, G; Wassmann, S; Niessner, A; Schmidt, TA; Saely, CH; Baumgartner, I; Tamargo, J.

Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review

European Heart Journal-Cardiovascular Pharmacotherapy. 2018; 4(4): 230-236 Nº de citas: 42 [doi:10.1093/ehjcvp/pvy028]

Perez-Hernandez, M; Matamoros, M; Alfayate, S; Nieto-Marin, P; Utrilla, RG; Tinaquero, D; de Andres, R; Crespo, T; Ponce-Balbuena, D; Willis, BC; Jimenez-Vazquez, EN; Guerrero-Serna, G; da Rocha, AM; Campbell, K; Herron, TJ; Diez-Guerra, FJ; Tamargo, J; Jalife, J; Caballero, R; Delpon, E.

Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels

Jci Insight. 2018; 3(18): Nº de citas: 40 [doi:10.1172/jci.insight.96291]

Rosano, GMC; Tamargo, J; Kjeldsen, KP; Lainscak, M; Agewall, S; Anker, SD; Ceconi, C; Coats, AJS; Drexel, H; Filippatos, G; Kaski, JC; Lund, L; Niessner, A; Ponikowski, P; Savarese, G; Schmidt, TA; Seferovic, P; Wassmann, S; Walther, T; Lewis, BS.

Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology

European Heart Journal-Cardiovascular Pharmacotherapy. 2018; 4(3): 180-188 Nº de citas: 158 [doi:10.1093/ehjcvp/pvy015]

Niessner, A; Tamargo, J; Koller, L; Saely, CH; Schmidt, TA; Savarese, G; Wassmann, S; Rosano, G; Ceconi, C; Torp-Pedersen, C; Kaski, JC; Kjeldsen, KP; Agewall, S; Walther, T; Drexel, H; Lewis, BS.

Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

EUROPEAN HEART JOURNAL. 2018; 39(24): 2274-2281 Nº de citas: 13 [doi:10.1093/eurheartj/ehx625]

Ponce-Balbuena, D; Guerrero-Serna, G; Valdivia, CR; Caballero, R; Diez-Guerra, FJ; Jimenez-Vazquez, EN; Ramirez, RJ; da Rocha, AM; Herron, TJ; Campbell, KF; Willis, BC; Alvarado, FJ; Zarzoso, M; Kaur, K; Perez-Hernandez, M; Matamoros, M; Valdivia, HH; Delpon, E; Jalife, J.

Cardiac Kir2.1 and Na(v)1.5 Channels Traffic Together to the Sarcolemma to Control Excitability

CIRCULATION RESEARCH. 2018; 122(11): 1501-1516 Nº de citas: 84 [doi:10.1161/CIRCRESAHA.117.311872]

Aboyans, V; Ricco, JB; Bartelink, MLEL; Bjorck, M; Brodmann, M; Cohnert, T; Collet, JP; Czerny, M; De Carlo, M; Debus, S; Espinola-Klein, C; Kahan, T; Kownator, S; Mazzolai, L; Naylor, AR; Roffi, M; Rother, J; Sprynger, M; Tendera, M; Tepe, G; Venermo, M; Vlachopoulos, C; Desormais, I; Widimsky, P; Kolh, P; Agewall, S; Bueno, H; Coca, A; De Borst, GJ; Delgado, V; Dick, F; Erol, C; Ferrini, M; Kakkos, S; Katus, HA; Knuuti, J; Lindholt, J; Mattle, H; Pieniazek, P; Piepoli, MF; Scheinert, D; Sievert, H; Simpson, I; Sulzenko, J; Tamargo, J; Tokgozoglu, L; Torbicki, A; Tsakountakis, N; Tunon, J; de Ceniga, MV; Windecker, S; Zamorano, JL.

Editor's Choice-2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2018; 55(3): 305-368 Nº de citas: 560 [doi:10.1016/j.ejvs.2017.07.018]

Subirana, I; Fito, M; Diaz, O; Vila, J; Frances, A; Delpon, E; Sanchis, J; Elosua, R; Munoz-Aguayo, D; Degano, IR; Marrugat, J.

Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism

Scientific Reports. 2018; 8: Nº de citas: 45 [doi:10.1038/s41598-018-21482-y]

Tamargo, J; Caballero, R; Delpon, E.

New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors

CARDIOVASCULAR DRUGS AND THERAPY. 2018; 32(1): 99-119 Nº de citas: 22 [doi:10.1007/s10557-017-6767-5]

Utrilla, RG; Nieto-Marin, P; Alfayate, S; Tinaquero, D; Matamoros, M; Perez-Hernandez, M; Sacristan, S; Ondo, L; de Andres, R; Diez-Guerra, FJ; Tamargo, J; Delpon, E; Caballero, R.

Kir2.1-Nav1.5 Channel Complexes Are Differently Regulated than Kir2.1 and Nav1.5 Channels Alone

Frontiers in Physiology. 2017; 8: Nº de citas: 37 [doi:10.3389/fphys.2017.00903]

Vonbank, A; Agewall, S; Kjeldsen, KP; Lewis, BS; Torp-Pedersen, C; Ceconi, C; Funck-Brentano, C; Kaski, JC; Niessner, A; Tamargo, J; Walther, T; Wassmann, S; Rosano, G; Schmidt, H; Saely, CH; Drexel, H.

Comprehensive efforts to increase adherence to statin therapy

EUROPEAN HEART JOURNAL. 2017; 38(32): 2473-112 Nº de citas: 54 [doi:10.1093/eurheartj/ehw628]

Tamargo, M; Tamargo, J.

Future drug discovery in renin-angiotensin-aldosterone system intervention

EXPERT OPINION ON DRUG DISCOVERY. 2017; 12(8): 827-848 Nº de citas: 27 [doi:10.1080/17460441.2017.1335301]

Tamargo, J; Rosano, G; Walther, T; Duarte, J; Niessner, A; Kaski, JC; Ceconi, C; Drexel, H; Kjeldsen, K; Savarese, G; Torp-Pedersen, C; Atar, D; Lewis, BS; Agewall, S.

Gender differences in the effects of cardiovascular drugs

European Heart Journal-Cardiovascular Pharmacotherapy. 2017; 3(3): 163-182 Nº de citas: 236 [doi:10.1093/ehjcvp/pvw042]

Niessner, A; Tamargo, J; Morais, J; Koller, L; Wassmann, S; Husted, SE; Torp-Pedersen, C; Kjeldsen, K; Lewis, BS; Drexel, H; Kaski, JC; Atar, D; Storey, RF; Lip, GYH; Verheugt, FWA; Agewall, S.

Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis

EUROPEAN HEART JOURNAL. 2017; 38(22): 1710-99 Nº de citas: 44 [doi:10.1093/eurheartj/ehv676]

Ruilope, LM; Tamargo, J.

Aldosterone a Relevant Factor in the Beginning and Evolution of Arterial Hypertension

AMERICAN JOURNAL OF HYPERTENSION. 2017; 30(5): 468-469 Nº de citas: 4 [doi:10.1093/ajh/hpx010]

Coll-Vinent, B; Martin, A; Sanchez, J; Tamargo, J; Suero, C; Malagon, F; Varona, M; Cancio, M; Sanchez, S; Carbajosa, J; Rios, J; Casanovas, G; Rafols, C; del Arco, C; EMERG-AF Investigators.

Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)

STROKE. 2017; 48(5): 1344 Nº de citas: 24 [doi:10.1161/STROKEAHA.116.014855]

Tamargo, J; Rosano, GMC; Delpon, E; Ruilope, L; Lopez-Sendon, J.

Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes

INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017; 233: 1-11 Nº de citas: 7 [doi:10.1016/j.ijcard.2016.11.124]